News
-
-
-
COMMUNIQUÉ DE PRESSE
Exosens delivers very strong full-year 2024 results, overperforming on its IPO guidance; Sustained growth dynamic anticipated for 2025-2026
Exosens delivers very strong full-year 2024 results, overperforming on its IPO guidance, with sustained growth dynamic anticipated for 2025-2026. Significant increase in profitability with best-in-class margin -
-
-
-
-
COMMUNIQUÉ DE PRESSE
Solid start to 2025 - Q1 Organic Growth tracking 3%; €321m EBITDA +5%, EBITDA margin 14.6% (+70bps); Cash generation +4%, EPS growth +22.5%
ARYZTA AG reports solid Q1 results for 2025 with 3% organic growth and €321m EBITDA, showing a 5% increase. EBITDA margin rises to 14.6% (+70bps) with cash generation up by 4% and EPS growth at 22.5% -
-
